What We Don’t Know
Can’t Heal Us
Today, investigation of this unique class of compounds is just beginning. We aim to drastically expand the scope of current industry research, targeting an abundance of the cannabinoids to unlock near-infinite pharmaceutical possibilities for custom-tailored combinations of cannabinoids and potencies.
Treehouse Biotech maintains an unwavering standard of ethical business practices, compliant procedures, and transparent sourcing.
in-house analytical capabilities, third-party analyses, and manufacturing accreditation. Analytical Instruments: LCMS, HPLC, UV Vis, NMR
We take a conservative approach to operations, adhering
to all industry-specific laws including FDA, OSHA, and CDPHE while anticipating future U.S. and international regulation
in our product development.
- CDPHE Food Manufacturer License – Current
- cGMP Certification – Expected December 2018
- ISO 9000 – Expected December 2018
- SQF – Expected February 2019
at the heart of our innovation. We refuse to settle for anything less than the complete utilization of every waste stream.
accounting firms. We only work with firms who are
regularly audited by the Big Five.
Subscribe to get the latest news and developments on our research of cannabinoids.
Treehouse Biotech is pioneering scientific advances in the chemistry and biochemistry of cannabinoids. With more than 70 known naturally-occurring cannabinoids, we recognize the immense unexplored potential of this unique class of compounds. Our team of trained organic, analytical, and natural product chemists is able to provide unique and advanced solutions for research and development in the industrial hemp space.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
© 2018 Treehouse Hemp